Michael R. Savona, MD
Director, Hematology Research
Vanderbilt University School of Medicine
Dr. Michael Savona received his medical degree from Wake Forest University School of Medicine in Winston-Salem, North Carolina. He completed his residency as active duty with the United States Air Force at the University of California in San Francisco and Sacramento, California, and his fellowship in hematology and oncology at the University of Michigan in Ann Arbor. He later served as faculty at the San Antonio Military Medical Center in the United States Air Force, and is a veteran of Operation Enduring Freedom/Operation Iraqi Freedom. Dr. Savona is an Associate Professor of Medicine at Vanderbilt University School of Medicine and serves as Director of Hematology Research and the Hematology Early Therapy Program Vanderbilt‐Ingram Cancer Center. He previously served as the Director of Leukemia Research, and Senior Investigator, Drug Development, at Sarah Cannon Research Institute, where he built a world-renown hematology phase I program.
Dr Savona is board certified in medical oncology and hematology, and is an elected fellow of the American College of Physicians. He is the founder and chairman of the MDS/MPN International Working Group, and the principal of the International Study of novel therapy for MDS/MPN: ABNL MARRO. Dr. Savona is a physician scientist and medical oncologist specializing in myeloid malignancies, and a leader in development of novel therapies for these diseases. His laboratory focuses on human cell biology with primary patient samples while examining novel compounds in the hopes of advancing them to the clinic.